Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Muir

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Chest|July 1, 1992
The significance of irregular opacities on the chest roentgenogramJ A Dick, W K Morgan, D F Muir, et al.
British Journal of Clinical Pharmacology|April 6, 1999
The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?L Swan, S Hood, D H Birnie, et al.
Clinical Science (London, England : 1979)|May 18, 2000
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?G P McCann, H Cahill, S Knipe, et al.
Heart (British Cardiac Society)|July 15, 2009
Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral arteryS L Hetherington, Z Adam, R Morley, et al.
Heart (British Cardiac Society)|November 23, 2007
External validation of established risk adjustment models for procedural complications after percutaneous coronary interventionB Kunadian, J Dunning, R Das, et al.
International Journal of Cardiology|May 3, 2016
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary interventionZ Adam, A Turley, J M Mason, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Chest|July 1, 1992
The significance of irregular opacities on the chest roentgenogramJ A Dick, W K Morgan, D F Muir, et al.
British Journal of Clinical Pharmacology|April 6, 1999
The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?L Swan, S Hood, D H Birnie, et al.
Clinical Science (London, England : 1979)|May 18, 2000
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?G P McCann, H Cahill, S Knipe, et al.
Heart (British Cardiac Society)|July 15, 2009
Primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction: changing patterns of vascular access, radial versus femoral arteryS L Hetherington, Z Adam, R Morley, et al.
Heart (British Cardiac Society)|November 23, 2007
External validation of established risk adjustment models for procedural complications after percutaneous coronary interventionB Kunadian, J Dunning, R Das, et al.
International Journal of Cardiology|May 3, 2016
The SSTARS (STeroids and Stents Against Re-Stenosis) Trial: Different stent alloys and the use of peri-procedural oral corticosteroids to prevent in-segment restenosis after percutaneous coronary interventionZ Adam, A Turley, J M Mason, et al.
Pageof 2